Evan/ Fa Jones Veracyte, Inc. (VCYT) insider trading activity

VCYT Quotes by TradingView

Evan/ Fa Jones is Director of VERACYTE, INC.. Currently has a direct ownership of 34,343 shares of VCYT, which is worth approximately $1.41 Million. The most recent transaction as insider was on Aug 13, 2024, when has been sold 20,457 shares (Common Stock) at a price of $32.11 per share, resulting in proceeds of $656,874. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.3K
0% 3M change
8.66% 12M change
Total Value Held $1.41 Million

EVAN/ FA JONES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 13 2024
SELL
Open market or private sale
$656,874 $32.11 p/Share
20,457 Reduced 37.33%
34,343 Common Stock
Aug 13 2024
BUY
Exercise of conversion of derivative security
$88,339 $10.41 p/Share
8,486 Added 13.41%
54,800 Common Stock
Aug 12 2024
SELL
Open market or private sale
$2,970 $30.01 p/Share
99 Reduced 0.21%
46,314 Common Stock
Aug 09 2024
SELL
Open market or private sale
$30,990 $30.03 p/Share
1,032 Reduced 2.18%
46,413 Common Stock
Aug 09 2024
BUY
Exercise of conversion of derivative security
$3,123 $10.41 p/Share
300 Added 0.63%
47,445 Common Stock
Aug 07 2024
SELL
Open market or private sale
$154,874 $30.32 p/Share
5,108 Reduced 10.16%
45,180 Common Stock
Aug 07 2024
BUY
Exercise of conversion of derivative security
$12,637 $10.41 p/Share
1,214 Added 2.36%
50,288 Common Stock
Jun 13 2024
BUY
Grant, award, or other acquisition
-
11,473 Added 18.95%
49,074 Common Stock
Mar 01 2024
SELL
Open market or private sale
$243,600 $24.36 p/Share
10,000 Reduced 21.01%
37,601 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
$131,900 $13.19 p/Share
10,000 Added 17.36%
47,601 Common Stock
Jul 19 2023
SELL
Open market or private sale
$25,257 $30.14 p/Share
838 Reduced 2.18%
37,601 Common Stock
Jul 18 2023
SELL
Open market or private sale
$70,091 $30.16 p/Share
2,324 Reduced 5.7%
38,439 Common Stock
Jul 17 2023
SELL
Open market or private sale
$574,186 $30.07 p/Share
19,095 Reduced 31.9%
40,763 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
9,674 Added 13.91%
59,858 Common Stock
Dec 14 2022
SELL
Open market or private sale
$18,078 $30.13 p/Share
600 Reduced 1.18%
50,184 Common Stock
Dec 13 2022
SELL
Open market or private sale
$51,810 $31.08 p/Share
1,667 Reduced 3.18%
50,784 Common Stock
Nov 11 2022
SELL
Open market or private sale
$183,720 $30.62 p/Share
6,000 Reduced 10.27%
52,451 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
14,731 Added 20.13%
58,451 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
$20,000 $4.0 p/Share
5,000 Added 10.26%
43,720 Common Stock
Jun 08 2021
BUY
Grant, award, or other acquisition
-
8,720 Added 18.38%
38,720 Common Stock
Jan 22 2021
BUY
Exercise of conversion of derivative security
$11,800 $2.36 p/Share
5,000 Added 14.29%
30,000 Common Stock

Also insider at

OPGN
OPGEN INC Healthcare
Director
EFJ

Evan/ Fa Jones

Director
South San Francisco, CA

Track Institutional and Insider Activities on VCYT

Follow VERACYTE, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCYT shares.

Notify only if

Insider Trading

Get notified when an Veracyte, Inc. insider buys or sells VCYT shares.

Notify only if

News

Receive news related to VERACYTE, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VCYT